Follow the Clover Health Investments, Corp. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was reported on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JAMIE REYNOSO. All data is accessible without an account.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Clover Health Investments, Corp. Buy (bullish), based on 3 analysts. Average price target: US$5.17.
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,883 of 28,958 companies
22.5
score / 100
Value
27
Quality
19
FCF yld-2.9%
Earn yld-3.1%
EV/EBITDA·
ROE-5.1%
Gross mgn13%
Net mgn-4.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
7,289 shares@ US$4.8959.9% of flowCommonSEC144:0001950047-26-005956
19 of 19 declarations
About Clover Health Investments, Corp.
Clover Health Investments, Corp. is a healthcare technology company that uses data to enhance patient care. It focuses on health insurance for seniors and at-risk populations.